ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag federal funding immunology disease medicine

Federal Health Agency Revokes Contract with Fetal Tissue Supplier
Sukanya Charuchandra | Sep 26, 2018 | 2 min read
Health and Human Services plans to review all research involving human fetal tissue.
Scientific Medicine and Chronic Fatigue Syndrome
Mary Mcnamara | Nov 12, 2000 | 6 min read
Illustration: A. Canamucio There has never been a better time, technologically, for our federal health agencies to launch a significant effort to prevent and control a chronic disease that has inflicted suffering on mankind for centuries. Chronic fatigue syndrome (CFS) is the current name for an illness with many names and a long history. In 1681 Thomas Sydenham, founder of modern clinical, scientific, and public health medicine, described a disease spectrum identical to it called "muscular rheu
Biomed Caucus Members Express Cautious Optimism On Prospect For Boost In Federal Research Funds
Ron Kaufman | Apr 4, 1993 | 3 min read
University department chairpersons have been pushing to see dollar support for NIH double in the near future Five billion dollars is not enough, according to a group pushing for the federal government to pump more money into the basic biomedical research funded by the National Institutes of Health. And with Bill Clinton now in the White House, members of the group--the National Caucus of Basic Biomedical Science Chairs-- say they are very optimistic about achieving their goal. Composed of 2
Plague Of Mismanagement Infects Federal Agency's Malaria Project
Jim Anderson | Jul 9, 1989 | 9 min read
WASHINGTON—Malaria, a wily scourge that kills from one to three million human beings each year, now finds itself associated with a victim of another sort: a 15-year-old, $100 million federally funded program to develop a vaccine against this ancient threat. Wracked by internal bickering, distracted by lawsuits and investigations, and stymied by a lack of progress, the Agency for International Development’s (AID) malaria project has fallen years behind in its’ search for an e
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Albert Einstein College of Medicine
The Scientist Staff | Nov 21, 2004 | 4 min read
Next year marks the 50th anniversary of the opening of the Albert Einstein College of Medicine of Yeshiva University.
the facade of a building. crisscrossed white walls intersect sets of four black windows in a lattice structure, with a cloudless blue sky in the background.
Exosome Scientist Douglas Taylor Stole and Mislabeled Images: Report
Katherine Irving | Nov 23, 2022 | 2 min read
Taylor, formerly of the University of Louisville, is known for his discovery of and research on tumor-secreted exosomes.  
Chronic Fatigue Syndrome Reframed
Kerry Grens | Feb 11, 2015 | 2 min read
To more accurately reflect the condition, the Institute of Medicine recommends renaming it systemic exertion intolerance disease.
Is Corporate Research Funding Leading To Secrecy In Science?
Steven Benowitz | Apr 1, 1996 | 10 min read
Science? Many from academia and industry dispute an NCI scientist's charge that confidentiality agreements restrict the free exchange of information. CONCERNED: NCI's Steven Rosenberg worries that research agreements promote secrecy among scientists. Few scientists with research support from industry complain in these times of increasing competition for grants from federal agencies. Yet some investigators are concerned that corporate desires to keep firm control over so-called proprietary in
dual expresser t cell immunology type 1 diabetes
The Science News that Shaped 2019
Kerry Grens | Dec 20, 2019 | 6 min read
A T cell discovery, “hachimoji” DNA, a new species of human, and mounting fears of espionage rounded off the list this year.

Run a Search

ADVERTISEMENT